Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| LENSAR, Inc. | 550,641 | reported | 23 May 2025 | tx 8+192,742 |
| Tarsus Pharmaceuticals, Inc. | 116,332 | reported | 16 Mar 2026 | tx 43+1,321,649−2,407,756 |
| Vivani Medical, Inc. | 56,685 | reported | 04 Jun 2019 | tx 6+197,840 |
| RxSight, Inc. | 37,855 | reported | 03 Jun 2025 | tx 26+2,801,255−4,758,930 |
| Inogen Inc | 36,331 | reported | 18 Dec 2014 | tx 31+3,845,572−2,341,593 |
| GLAUKOS Corp | 17,821 | reported | 03 Jun 2021 | tx 76+3,521,057−4,019,772 |
| Edwards Lifesciences Corp | 11,004 | reported | 08 May 2020 | tx 35+42,858−60,792 |
| Oyster Point Pharma, Inc. | 2,074 | reported | 05 Jan 2022 | tx 24+2,726,432−4,125,563 |
| ADVANCED MEDICAL OPTICS INC | 0 | reported | 26 Feb 2009 | tx 18+38,510−40,407 |
| INTRALASE CORP | 0 | reported | 02 Apr 2007 | tx 56+15,400−4,864,950 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Mar 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 8,378 | 69.03 USD | |
| 16 Mar 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 493 | 69.75 USD | |
| 16 Mar 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 3,629 | 68.09 USD | |
| 15 Dec 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 5,046 | 80.80 USD | |
| 15 Dec 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 1,148 | 82.39 USD | |
| 15 Dec 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 5,680 | 80.71 USD | |
| 15 Dec 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 4,766 | 81.50 USD | |
| 15 Dec 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 6,306 | 81.75 USD | |
| 16 Sept 2025 | GIFT | Tarsus Pharmaceuticals, Inc. | 2,000 | 0.00 USD | |
| 08 Sept 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 27,116 | 57.00 USD | |
| 13 Jun 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 3,350 | — | |
| 12 Jun 2025 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 4,540 | 0.00 USD | deriv |
| 12 Jun 2025 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 2,954 | 0.00 USD | deriv |
| 13 Jun 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 3,350 | 0.00 USD | deriv |
| 03 Jun 2025 | GRANT_AWARD | RxSight, Inc. | 10,752 | — | |
| 23 May 2025 | GRANT_AWARD | LENSAR, Inc. | 7,374 | 0.00 USD | |
| 12 Aug 2024 | SALE | Tarsus Pharmaceuticals, Inc. | 29,979 | 26.01 USD | |
| 12 Aug 2024 | SALE | Tarsus Pharmaceuticals, Inc. | 5,021 | 26.53 USD | |
| 12 Aug 2024 | OTHER | Tarsus Pharmaceuticals, Inc. | 10,446 | 0.00 USD | |
| 12 Aug 2024 | OTHER | Tarsus Pharmaceuticals, Inc. | 74,892 | 0.00 USD | |
| 12 Aug 2024 | OTHER | Tarsus Pharmaceuticals, Inc. | 27,116 | 0.00 USD | |
| 24 Jun 2024 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 3,350 | — | |
| 24 Jun 2024 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 3,350 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 3,350 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 5,000 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 03 Aug 2021.